Piceatannol, a Structural Analog of Resveratrol, Is an Apoptosis Inducer and a Multidrug Resistance Modulator in HL-60 Human Acute Myeloid Leukemia Cells
Abstract
:1. Introduction
2. Results
2.1. Effect of Piceatannol on the Viability and Cell Cycle Distribution of HL-60 Cells
2.2. Effect of Piceatannol on Reactive Oxygen Species Production in HL-60 Cells
2.3. Effect of Piceatannol on Autophagy Pathways
2.4. Induction of Cell Death in Piceatannol-Treated HL-60 Cells
2.5. Effects of Piceatannol on the Activity and Expression of P-gp
2.6. Effects of Piceatannol on the Activity and Expression of MRP1
2.7. Effects of Piceatannol on the Activity and Expression of BCRP
3. Discussion
4. Materials and Methods
4.1. Chemicals
4.2. Cell Culture
4.3. Cytotoxicity Assay
4.4. Cell Cycle Analysis
4.5. Annexin V-FITC/PI Assay
4.6. Caspase-3 Activity Assay
4.7. Analysis of the Mitochondrial Membrane Potential
4.8. DNA Fragmentation Assay
4.9. Detection of Intracellular Production of Reactive Oxygen Species
4.10. Western Blotting Analysis
4.11. Immunofluorescent Analysis
4.12. Rhodamine 123 Uptake/Retention Assay
4.13. Detection of P-gp
4.14. Detection of MRP1
4.15. Detection of BCRP
4.16. Statistical Analysis
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Grove, C.S.; Vassiliou, G.S. Acute myeloid leukaemia: A paradigm for the clonal evolution of cancer? Dis. Models Mech. 2014, 7, 941–951. [Google Scholar] [CrossRef] [Green Version]
- Seth, R.; Singh, A. Leukemias in Children. Indian J. Pediatr. 2015, 82, 817–824. [Google Scholar] [CrossRef] [PubMed]
- De Kouchkovsky, I.; Abdul-Hay, M. Acute myeloid leukemia: A comprehensive review and 2016 update. Blood Cancer J. 2016, 6, e441. [Google Scholar] [CrossRef] [PubMed]
- Heuser, M.; Ofran, Y.; Boissel, N.; Mauri, S.B.; Craddock, C.; Janssen, J.; Wierzbowska, A.; Buske, C. Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2020, 31, 697–712. [Google Scholar] [CrossRef] [PubMed]
- Chen, A.; Hu, S.; Wang, Q.-F. Tumor heterogeneity of acute myeloid leukemia: Insights from single-cell sequencing. Blood Sci. 2019, 1, 73–76. [Google Scholar] [CrossRef]
- Elgarten, C.W.; Aplenc, R. Pediatric acute myeloid leukemia: Updates on biology, risk stratification, and therapy. Curr. Opin. Pediatr. 2020, 32, 57–66. [Google Scholar] [CrossRef] [PubMed]
- Pelcovits, A.; Niroula, R. Acute Myeloid Leukemia: A Review. R. I. Med. J. (2013) 2020, 103, 38–40. [Google Scholar]
- Stomper, J.; Rotondo, J.C.; Greve, G.; Lübbert, M. Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: Mechanisms of resistance and novel HMA-based therapies. leukemia 2021, 35, 1873–1889. [Google Scholar] [CrossRef] [PubMed]
- Júnior, L.S.D.S.; Soares, V.D.L.; Da Silva, A.S.J.; Gil, E.A.; Araújo, M.D.G.P.D.; Gonçalves, C.A.M.; Paiva, A.D.S.; De Oliveira, T.M.M.; Oliveira, G.H.D.M.; E Silva, D.G.K.C.; et al. P-glycoprotein and multidrug resistance-associated protein-1 expression in acute myeloid leukemia: Biological and prognosis implications. Int. J. Lab. Hematol. 2020, 42, 594–603. [Google Scholar] [CrossRef]
- Vasconcelos, F.C.; de Souza, P.S.; Hancio, T.; de Faria, F.C.C.; Maia, R.C. Update on drug transporter proteins in acute myeloid leukemia: Pathological implication and clinical setting. Crit. Rev. Oncol. 2021, 160, 103281. [Google Scholar] [CrossRef]
- Robey, R.; Pluchino, K.M.; Hall, M.D.; Fojo, A.T.; Bates, S.E.; Gottesman, M.M. Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat. Rev. Cancer 2018, 18, 452–464. [Google Scholar] [CrossRef]
- Vasiliou, V.; Vasiliou, K.; Nebert, D.W. Human ATP-binding cassette (ABC) transporter family. Hum. Genom. 2008, 3, 281–290. [Google Scholar] [CrossRef]
- Wang, J.; Wu, Z.; Yang, Y.; Teng, Q.; Li, Y.; Lei, Z.; A Jani, K.; Kaushal, N.; Chen, Z. ATP-binding cassette (ABC) transporters in cancer: A review of recent updates. J. Evidence-Based Med. 2021, 14, 232–256. [Google Scholar] [CrossRef]
- Choi, Y.; Yu, A.-M. ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development. Curr. Pharm. Des. 2014, 20, 793–807. [Google Scholar] [CrossRef]
- Cordon-Cardo, C.; O’Brien, J.P.; Boccia, J.; Casals, D.; Bertino, J.R.; Melamed, M.R. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J. Histochem. Cytochem. 1990, 38, 1277–1287. [Google Scholar] [CrossRef] [PubMed]
- Doyle, L.A.; Yang, W.; Abruzzo, L.V.; Krogmann, T.; Gao, Y.; Rishi, A.K.; Ross, D.D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA 1998, 95, 15665–15670. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Geier, E.G.; Chen, E.C.; Webb, A.; Papp, A.C.; Yee, S.W.; Sadee, W.; Giacomini, K.M. Profiling Solute Carrier Transporters in the Human Blood–Brain Barrier. Clin. Pharmacol. Ther. 2013, 94, 636–639. [Google Scholar] [CrossRef] [PubMed]
- Hart, S.M.; Ganeshaguru, K.; Hoffbrand, A.V.; Prentice, H.G.; Mehta, A.B. Expression of the multidrug resistance-associated protein (MRP) in acute leukaemia. Leukemia 1994, 8, 2163–2168. [Google Scholar] [PubMed]
- Ross, D.D.; E Karp, J.; Chen, T.T.; A Doyle, L. Expression of breast cancer resistance protein in blast cells from patients with acute leukemia. Blood 2000, 96, 365–368. [Google Scholar] [CrossRef]
- Lewinson, O.; Orelle, C.; Seeger, M.A. Structures of ABC transporters: Handle with care. FEBS Lett. 2020, 594, 3799–3814. [Google Scholar] [CrossRef]
- Arana, M.R.; Altenberg, G.A. ATP-binding Cassette Exporters: Structure and Mechanism with a Focus on P-glycoprotein and MRP1. Curr. Med. Chem. 2019, 26, 1062–1078. [Google Scholar] [CrossRef]
- Xing, J.; Huang, S.; Heng, Y.; Mei, H.; Pan, X. Computational Insights into Allosteric Conformational Modulation of P-Glycoprotein by Substrate and Inhibitor Binding. Molecules 2020, 25, 6006. [Google Scholar] [CrossRef]
- Saaby, L.; Brodin, B. A Critical View on In Vitro Analysis of P-glycoprotein (P-gp) Transport Kinetics. J. Pharm. Sci. 2017, 106, 2257–2264. [Google Scholar] [CrossRef] [Green Version]
- Lu, J.F.; Pokharel, D.; Bebawy, M. MRP1 and its role in anticancer drug resistance. Drug Metab. Rev. 2015, 47, 406–419. [Google Scholar] [CrossRef]
- Cole, S.P. Targeting Multidrug Resistance Protein 1 (MRP1,ABCC1): Past, Present, and Future. Annu. Rev. Pharmacol. Toxicol. 2014, 54, 95–117. [Google Scholar] [CrossRef]
- Safar, Z.; Kis, E.; Erdo, F.; Zolnerciks, J.K.; Krajcsi, P. ABCG2/BCRP: Variants, transporter interaction profile of substrates and inhibitors. Expert Opin. Drug Metab. Toxicol. 2019, 15, 313–328. [Google Scholar] [CrossRef] [PubMed]
- Hira, D.; Terada, T. BCRP/ABCG2 and high-alert medications: Biochemical, pharmacokinetic, pharmacogenetic, and clinical implications. Biochem. Pharmacol. 2018, 147, 201–210. [Google Scholar] [CrossRef] [PubMed]
- Marie, J.P.; Zittoun, R.; Sikic, B.I. Multidrug resistance (mdr1) gene expression in adult acute leukemias: Correlations with treatment outcome and in vitro drug sensitivity. Blood 1991, 78, 586–592. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Steinbach, D.; Legrand, O. ABC transporters and drug resistance in leukemia: Was P-gp nothing but the first head of the Hydra? Leukemia 2007, 21, 1172–1176. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Legrand, O.; Simonin, G.; Perrot, J.Y.; Zittoun, R.; Marie, J.P. Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients. Blood 1998, 91, 4480–4488. [Google Scholar] [CrossRef]
- Te Boekhorst, P.A.; de Leeuw, K.; Schoester, M.; Wittebol, S.; Nooter, K.; Hagemeijer, A.; Löwenberg, B.; Sonneveld, P. Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells. Blood 1993, 82, 3157–3162. [Google Scholar] [CrossRef] [Green Version]
- Steinbach, D.; Sell, W.; Voigt, A.; Hermann, J.; Zintl, F.; Sauerbrey, A. BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia. Leukemia 2002, 16, 1443–1447. [Google Scholar] [CrossRef]
- Marzac, C.; Garrido, E.; Tang, R.; Fava, F.; Hirsch, P.; De Benedictis, C.; Corre, E.; Lapusan, S.; Lallemand, J.-Y.; Marie, J.-P.; et al. ATP Binding Cassette transporters associated with chemoresistance: Transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients. Haematologica 2011, 96, 1293–1301. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Matsui, Y.; Sugiyama, K.; Kamei, M.; Takahashi, T.; Suzuki, T.; Katagata, Y.; Ito, T. Extract of Passion Fruit (Passiflora edulis) Seed Containing High Amounts of Piceatannol Inhibits Melanogenesis and Promotes Collagen Synthesis. J. Agric. Food Chem. 2010, 58, 11112–11118. [Google Scholar] [CrossRef] [PubMed]
- Rimando, A.M.; Kalt, W.; Magee, J.B.; Dewey, A.J.; Ballington, J.R. Resveratrol, Pterostilbene, and Piceatannol in Vaccinium Berries. J. Agric. Food Chem. 2004, 52, 4713–4719. [Google Scholar] [CrossRef] [PubMed]
- Viñas, P.; Campillo, N.; Martínez-Castillo, N.; Hernandez-Cordoba, M. Solid-phase microextraction on-fiber derivatization for the analysis of some polyphenols in wine and grapes using gas chromatography–mass spectrometry. J. Chromatogr. A 2009, 1216, 1279–1284. [Google Scholar] [CrossRef]
- Cantos-Villar, E.; Espin, J.C.; Fernández, M.J.; Oliva, J.; Tomás-Barberán, F.A. Postharvest UV-C-Irradiated Grapes as a Potential Source for Producing Stilbene-Enriched Red Wines. J. Agric. Food Chem. 2003, 51, 1208–1214. [Google Scholar] [CrossRef] [PubMed]
- Bastianetto, S.; Dumont, Y.; Han, Y.; Quirion, R. Comparative Neuroprotective Properties of Stilbene and Catechin Analogs: Action Via a Plasma Membrane Receptor Site? CNS Neurosci. Ther. 2009, 15, 76–83. [Google Scholar] [CrossRef] [PubMed]
- Docherty, J.J.; McEwen, H.A.; Sweet, T.J.; Bailey, E.; Booth, T.D. Resveratrol inhibition of Propionibacterium acnes. J. Antimicrob. Chemother. 2007, 59, 1182–1184. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hung, L. Beneficial effects of astringinin, a resveratrol analogue, on the ischemia and reperfusion damage in rat heart. Free Radic. Biol. Med. 2001, 30, 877–883. [Google Scholar] [CrossRef]
- Liu, L.; Li, J.; Kundu, J.K.; Surh, Y.-J. Piceatannol inhibits phorbol ester-induced expression of COX-2 and iNOS in HR-1 hairless mouse skin by blocking the activation of NF-κB and AP-1. Inflamm. Res. 2014, 63, 1013–1021. [Google Scholar] [CrossRef]
- Maggiolini, M.; Recchia, A.G.; Bonofiglio, D.; Catalano, S.; Vivacqua, A.; Carpino, A.; Rago, V.; Rossi, R.; Andò, S. The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor α in human breast cancer cells. J. Mol. Endocrinol. 2005, 35, 269–281. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Minakawa, M.; Miura, Y.; Yagasaki, K. Piceatannol, a resveratrol derivative, promotes glucose uptake through glucose transporter 4 translocation to plasma membrane in L6 myocytes and suppresses blood glucose levels in type 2 diabetic model db/db mice. Biochem. Biophys. Res. Commun. 2012, 422, 469–475. [Google Scholar] [CrossRef] [PubMed]
- Murias, M.; Jäger, W.; Handler, N.; Erker, T.; Horvath, Z.; Szekeres, T.; Nohl, H.; Gille, L. Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: Structure–activity relationship. Biochem. Pharmacol. 2005, 69, 903–912. [Google Scholar] [CrossRef] [PubMed]
- Chowdhury, S.A.; Kishino, K.; Satoh, R.; Hashimoto, K.; Kikuchi, H.; Nishikawa, H.; Shirataki, Y.; Sakagami, H. Tumor-specificity and apoptosis-inducing activity of stilbenes and flavonoids. Anticancer. Res. 2005, 25, 2055–2063. [Google Scholar] [PubMed]
- Hsieh, T.-C.; Lin, C.-Y.; Lin, H.-Y.; Wu, J.M. AKT/mTOR as Novel Targets of Polyphenol Piceatannol Possibly Contributing to Inhibition of Proliferation of Cultured Prostate Cancer Cells. ISRN Urol. 2012, 2012, 1–8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kang, C.-H.; Moon, D.-O.; Choi, Y.H.; Choi, I.-W.; Moon, S.-K.; Kim, W.-J.; Kim, G.-Y. Piceatannol enhances TRAIL-induced apoptosis in human leukemia THP-1 cells through Sp1- and ERK-dependent DR5 up-regulation. Toxicol. Vitr. 2011, 25, 605–612. [Google Scholar] [CrossRef] [PubMed]
- Kim, Y.H.; Park, C.; Lee, J.O.; Kim, G.Y.; Lee, W.H.; Choi, Y.H.; Ryu, C.H. Induction of apoptosis by piceatannol in human leukemic U937 cells through down-regulation of Bcl-2 and activation of caspases. Oncol. Rep. 2008, 19, 961–967. [Google Scholar] [CrossRef] [Green Version]
- Tolomeo, M.; Grimaudo, S.; Di Cristina, A.; Roberti, M.; Pizzirani, D.; Meli, M.; Dusonchet, L.; Gebbia, N.; Abbadessa, V.; Crosta, L.; et al. Pterostilbene and 3′-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells. Int. J. Biochem. Cell Biol. 2005, 37, 1709–1726. [Google Scholar] [CrossRef]
- Kuo, P.-L.; Hsu, Y.-L. The grape and wine constituent piceatannol inhibits proliferation of human bladder cancer cells via blocking cell cycle progression and inducing Fas/membrane bound Fas ligand-mediated apoptotic pathway. Mol. Nutr. Food Res. 2008, 52, 408–418. [Google Scholar] [CrossRef]
- Larrosa, M.; Tomás-Barberán, F.A.; Espín, J.C. The grape and wine polyphenol piceatannol is a potent inducer of apoptosis in human SK-Mel-28 melanoma cells. Eur. J. Nutr. 2004, 43, 275–284. [Google Scholar] [CrossRef] [PubMed]
- Lee, Y.M.; Lim, D.Y.; Cho, H.J.; Seon, M.R.; Kim, J.-K.; Lee, B.-Y.; Park, J.H.Y. Piceatannol, a natural stilbene from grapes, induces G1 cell cycle arrest in androgen-insensitive DU145 human prostate cancer cells via the inhibition of CDK activity. Cancer Lett. 2009, 285, 166–173. [Google Scholar] [CrossRef] [PubMed]
- Liu, W.-H.; Chang, L.-S. Piceatannol induces Fas and FasL up-regulation in human leukemia U937 cells via Ca2+/p38α MAPK-mediated activation of c-Jun and ATF-2 pathways. Int. J. Biochem. Cell Biol. 2010, 42, 1498–1506. [Google Scholar] [CrossRef] [PubMed]
- Morales, P.; Haza, A.I. Selective apoptotic effects of piceatannol and myricetin in human cancer cells. J. Appl. Toxicol. 2012, 32, 986–993. [Google Scholar] [CrossRef] [PubMed]
- Vo, N.T.; Madlener, S.; Bago-Horvath, Z.; Herbacek, I.; Stark, N.; Gridling, M.; Probst, P.; Giessrigl, B.; Bauer, S.; Vonach, C.; et al. Pro- and anticarcinogenic mechanisms of piceatannol are activated dose dependently in MCF-7 breast cancer cells. Carcinogenesis 2009, 31, 2074–2081. [Google Scholar] [CrossRef] [Green Version]
- Wieder, T.; Prokop, A.; Bagci, B.; Essmann, F.; Bernicke, D.; Schulze-Osthoff, K.; Dörken, B.; Schmalz, H.-G.; Daniel, P.; Henze, G. Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts. Leukemia 2001, 15, 1735–1742. [Google Scholar] [CrossRef] [Green Version]
- Wolter, F.; Clausnitzer, A.; Akoglu, B.; Stein, J. Piceatannol, a Natural Analog of Resveratrol, Inhibits Progression through the S Phase of the Cell Cycle in Colorectal Cancer Cell Lines. J. Nutr. 2002, 132, 298–302. [Google Scholar] [CrossRef] [Green Version]
- Zhang, H.; Jia, R.; Wang, C.; Hu, T.; Wang, F. Piceatannol promotes apoptosis via up-regulation of microRNA-129 expression in colorectal cancer cell lines. Biochem. Biophys. Res. Commun. 2014, 452, 775–781. [Google Scholar] [CrossRef]
- Siedlecka-Kroplewska, K.; Ślebioda, T.; Kmieć, Z. Induction of autophagy, apoptosis and aquisition of resistance in response to piceatannol toxicity in MOLT-4 human leukemia cells. Toxicol. Vitr. 2019, 59, 12–25. [Google Scholar] [CrossRef]
- Pietrocola, F.; Mariño, G.; Lissa, D.; Vacchelli, E.; Malik, S.A.; Niso-Santano, M.; Zamzami, N.; Galluzzi, L.; Maiuri, M.C.; Kroemer, G. Pro-autophagic polyphenols reduce the acetylation of cytoplasmic proteins. Cell Cycle 2012, 11, 3851–3860. [Google Scholar] [CrossRef] [Green Version]
- Li, Y.; Guo, Y.; Feng, Z.; Bergan, R.; Li, B.; Qin, Y.; Zhao, L.; Zhang, Z.; Shi, M. Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR Cells. Nutr. Cancer 2019, 71, 1007–1018. [Google Scholar] [CrossRef]
- Huang, F.; Wu, X.-N.; Chen, J.; Wang, W.-X.; Lu, Z. Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells. Exp. Ther. Med. 2014, 7, 1611–1616. [Google Scholar] [CrossRef]
- Mieszala, K.; Rudewicz, M.; Gomułkiewicz, A.; Ratajczak-Wielgomas, K.; Grzegrzółka, J.; Dziegiel, P.; Borska, S. Expression of genes and proteins of multidrug resistance in gastric cancer cells treated with resveratrol. Oncol. Lett. 2018, 15, 5825–5832. [Google Scholar] [CrossRef] [PubMed]
- Collins, S.J. The HL-60 promyelocytic leukemia cell line: Proliferation, differentiation, and cellular oncogene expression. Blood 1987, 70, 1233–1244. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Drexler, H.; Quentmeier, H.; MacLeod, R.; Uphoff, C.; Hu, Z.-B. Leukemia cell lines: In vitro models for the study of acute promyelocytic leukemia. Leuk. Res. 1995, 19, 681–691. [Google Scholar] [CrossRef]
- López-Lázaro, M. A simple and reliable approach for assessing anticancer activity in vitro. Curr. Med. Chem. 2015, 22, 1324–1334. [Google Scholar] [CrossRef] [PubMed]
- Eskelinen, E.-L. Maturation of Autophagic Vacuoles in Mammalian Cells. Autophagy 2005, 1, 1–10. [Google Scholar] [CrossRef] [Green Version]
- Kabeya, Y.; Mizushima, N.; Ueno, T.; Yamamoto, A.; Kirisako, T.; Noda, T.; Kominami, E.; Ohsumi, Y.; Yoshimori, T. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000, 19, 5720–5728. [Google Scholar] [CrossRef] [PubMed]
- Beck, W.T.; Grogan, T.M.; Willman, C.L.; Cordon-Cardo, C.; Parham, D.M.; Kuttesch, J.F.; Andreeff, M.; E Bates, S.; Berard, C.W.; Boyett, J.M.; et al. Methods to detect P-glycoprotein-associated multidrug resistance in patients’ tumors: Consensus recommendations. Cancer Res. 1996, 56, 3010–3020. [Google Scholar] [PubMed]
- Huet, S.; Marie, J.-P.; Gualde, N.; Robert, J. Reference method for detection of Pgp mediated multidrug resistance in human hematological malignancies: A method validated by the laboratories of the French Drug Resistance Network. Cytometry 1998, 34, 248–256. [Google Scholar] [CrossRef]
- Ludescher, C.; Thaler, J.; Drach, D.; Drach, J.; Spitaler, M.; Gattringer, C.; And, H.H.; Hofmann, J. Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123. Br. J. Haematol. 1992, 82, 161–168. [Google Scholar] [CrossRef]
- Daoud, R.; Kast, C.; Gros, P.; Georges, E. Rhodamine 123 Binds to Multiple Sites in the Multidrug Resistance Protein (MRP1). Biochemistry 2000, 39, 15344–15352. [Google Scholar] [CrossRef]
- Twentyman, P.; Rhodes, T.; Rayner, S. A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes. Eur. J. Cancer 1994, 30, 1360–1369. [Google Scholar] [CrossRef]
- Qadir, M.; O’Loughlin, K.L.; Fricke, S.M.; Williamson, N.A.; Greco, W.R.; Minderman, H.; Baer, M.R. Cyclosporin A Is a Broad-Spectrum Multidrug Resistance Modulator. Clin. Cancer Res. 2005, 11, 2320–2326. [Google Scholar] [CrossRef] [Green Version]
- Leier, I.; Jedlitschky, G.; Buchholz, U.; Cole, S.P.; Deeley, R.G.; Keppler, D. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J. Biol. Chem. 1994, 269, 27807–27810. [Google Scholar] [CrossRef]
- Honjo, Y.; A Hrycyna, C.; Yan, Q.W.; Medina-Pérez, W.Y.; Robey, R.; Van De Laar, A.; Litman, T.; Dean, M.; E Bates, S. Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. Cancer Res. 2001, 61, 6635–6639. [Google Scholar] [PubMed]
- Allen, J.D.; Van Loevezijn, A.; Lakhai, J.M.; Van Der Valk, M.; Van Tellingen, O.; Reid, G.; Schellens, J.H.M.; Koomen, G.-J.; Schinkel, A.H. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol. Cancer Ther. 2002, 1, 417–425. [Google Scholar] [PubMed]
- Ejendal, K.F.K.; Diop, N.K.; Schweiger, L.C.; Hrycyna, C.A. The nature of amino acid 482 of human ABCG2 affects substrate transport and ATP hydrolysis but not substrate binding. Protein Sci. 2006, 15, 1597–1607. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Özvegy-Laczka, C.; Laczkó, R.; Hegedűs, C.; Litman, T.; Várady, G.; Goda, K.; Hegedűs, T.; Dokholyan, N.; Sorrentino, B.P.; Váradi, A.; et al. Interaction with the 5D3 Monoclonal Antibody Is Regulated by Intramolecular Rearrangements but Not by Covalent Dimer Formation of the Human ABCG2 Multidrug Transporter. J. Biol. Chem. 2008, 283, 26059–26070. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yokozawa, T.; Kim, Y.J. Piceatannol Inhibits Melanogenesis by Its Antioxidative Actions. Biol. Pharm. Bull. 2007, 30, 2007–2011. [Google Scholar] [CrossRef] [Green Version]
- Siedlecka-Kroplewska, K.; Jozwik, A.; Kaszubowska, L.; Kowalczyk, A.; Boguslawski, W. Pterostilbene induces cell cycle arrest and apoptosis in MOLT4 human leukemia cells. Folia Histochem. Et Cytobiol. 2012, 50, 574–580. [Google Scholar] [CrossRef]
- Siedlecka-Kroplewska, K.; Jozwik, A.; Boguslawski, W.; Woźniak, M.; Zauszkiewicz-Pawlak, A.; Spodnik, J.H.; Rychłowski, M.; Kmiec, Z. Pterostilbene induces accumulation of autophagic vacuoles followed by cell death in HL60 human leukemia cells. J. Physiol. Pharmacol. Off. J. Pol. Physiol. Soc. 2013, 64, 545–556. [Google Scholar]
- Siedlecka-Kroplewska, K.; Wozniak, M.; Kmiec, Z. The wine polyphenol resveratrol modulates autophagy and induces apoptosis in MOLT-4 and HL-60 human leukemia cells. J Physiol Pharmacol 2020, 70, 825–838. [Google Scholar]
- Qu, X.; Yu, J.; Bhagat, G.; Furuya, N.; Hibshoosh, H.; Troxel, A.; Rosen, J.; Eskelinen, E.-L.; Mizushima, N.; Ohsumi, Y.; et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Investig. 2003, 112, 1809–1820. [Google Scholar] [CrossRef] [Green Version]
- Yue, Z.; Jin, S.; Yang, C.; Levine, A.J.; Heintz, N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc. Natl. Acad. Sci. USA 2003, 100, 15077–15082. [Google Scholar] [CrossRef] [Green Version]
- Ma, X.-H.; Piao, S.; Wang, D.; McAfee, Q.W.; Nathanson, K.; Lum, J.J.; Li, L.; Amaravadi, R.K. Measurements of Tumor Cell Autophagy Predict Invasiveness, Resistance to Chemotherapy, and Survival in Melanoma. Clin. Cancer Res. 2011, 17, 3478–3489. [Google Scholar] [CrossRef] [Green Version]
- Marino, M.; Fais, S.; Djavaheri-Mergny, M.; Villa, A.; Meschini, S.; Lozupone, F.; Venturi, G.; Della Mina, P.; Pattingre, S.; Rivoltini, L.; et al. Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells. Cell Death Dis. 2010, 1, e87. [Google Scholar] [CrossRef] [Green Version]
- Musial, C.; Siedlecka-Kroplewska, K.; Kmiec, Z.; Gorska-Ponikowska, M. Modulation of Autophagy in Cancer Cells by Dietary Polyphenols. Antioxidants 2021, 10, 123. [Google Scholar] [CrossRef]
- Lang, F.; Qin, Z.; Li, F.; Zhang, H.; Fang, Z.; Hao, E. Apoptotic Cell Death Induced by Resveratrol Is Partially Mediated by the Autophagy Pathway in Human Ovarian Cancer Cells. PLOS ONE 2015, 10, e0129196. [Google Scholar] [CrossRef]
- Tang, Q.; Li, G.; Wei, X.; Zhang, J.; Chiu, J.-F.; Hasenmayer, D.; Zhang, D.; Zhang, H. Resveratrol-induced apoptosis is enhanced by inhibition of autophagy in esophageal squamous cell carcinoma. Cancer Lett. 2013, 336, 325–337. [Google Scholar] [CrossRef]
- Cros, E.; Jordheim, L.; Dumontet, C.; Galmarini, C.M. Problems Related to Resistance to Cytarabine in Acute Myeloid Leukemia. Leuk. Lymphoma 2004, 45, 1123–1132. [Google Scholar] [CrossRef]
- Chen, J.; Wei, H.; Cheng, J.; Xie, B.; Wang, B.; Yi, J.; Tian, B.; Liu, Z.; Wang, F.; Zhang, Z. Characteristics of doxorubicin-selected multidrug-resistant human leukemia HL-60 cells with tolerance to arsenic trioxide and contribution of leukemia stem cells. Oncol. Lett. 2017, 15, 1255–1262. [Google Scholar] [CrossRef] [PubMed]
- Baran, Y.; Gür, B.; Kaya, P.; Ural, A.U.; Avcu, F.; Gündüz, U. Upregulation of multi drug resistance genes in doxorubicin resistant human acute myelogeneous leukemia cells and reversal of the resistance. Hematology 2007, 12, 511–517. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lin, K.-N.; Jiang, Y.-L.; Zhang, S.-G.; Huang, S.-Y.; Li, H. Grape seed proanthocyanidin extract reverses multidrug resistance in HL-60/ADR cells via inhibition of the PI3K/Akt signaling pathway. Biomed. Pharmacother. 2020, 125, 109885. [Google Scholar] [CrossRef] [PubMed]
- De Figueiredo-Pontes, L.L.; Pintão, M.-C.T.; Oliveira, L.C.O.; Dalmazzo, L.F.F.; Jacomo, R.H.; Garcia, A.B.; Falcão, R.P.; Rego, E.M. Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia. Cytom. Part B Clin. Cytom. 2008, 74, 163–168. [Google Scholar] [CrossRef] [PubMed]
- Wesolowska, O.; Wisniewski, J.; Duarte, N.; Ferreira, M.J.U.; Michalak, K. Inhibition of MRP1 transport activity by phenolic and terpenic compounds isolated from Euphorbia species. Anticancer. Res. 2008, 27, 4127–4133. [Google Scholar]
- Augustin, E.; Moś-Rompa, A.; Skwarska, A.; Witkowski, J.M.; Konopa, J. Induction of G2/M phase arrest and apoptosis of human leukemia cells by potent antitumor triazoloacridinone C-1305. Biochem. Pharmacol. 2006, 72, 1668–1679. [Google Scholar] [CrossRef]
- Crabtree, G.R. Fc receptors of a human promyelocytic leukemic cell line: Evidence for two types of receptors defined by binding of the staphylococcal protein A-IgG1 complex. J. Immunol. 1980, 125, 448–453. [Google Scholar]
- Andersen, M.N.; Al-Karradi, S.N.H.; Kragstrup, T.W.; Hokland, M. Elimination of erroneous results in flow cytometry caused by antibody binding to Fc receptors on human monocytes and macrophages. Cytom. Part A 2016, 89, 1001–1009. [Google Scholar] [CrossRef]
- Maecker, H.T.; Trotter, J. Flow cytometry controls, instrument setup, and the determination of positivity. Cytom. Part A 2006, 69A, 1037–1042. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Siedlecka-Kroplewska, K.; Wrońska, A.; Kmieć, Z. Piceatannol, a Structural Analog of Resveratrol, Is an Apoptosis Inducer and a Multidrug Resistance Modulator in HL-60 Human Acute Myeloid Leukemia Cells. Int. J. Mol. Sci. 2021, 22, 10597. https://doi.org/10.3390/ijms221910597
Siedlecka-Kroplewska K, Wrońska A, Kmieć Z. Piceatannol, a Structural Analog of Resveratrol, Is an Apoptosis Inducer and a Multidrug Resistance Modulator in HL-60 Human Acute Myeloid Leukemia Cells. International Journal of Molecular Sciences. 2021; 22(19):10597. https://doi.org/10.3390/ijms221910597
Chicago/Turabian StyleSiedlecka-Kroplewska, Kamila, Agata Wrońska, and Zbigniew Kmieć. 2021. "Piceatannol, a Structural Analog of Resveratrol, Is an Apoptosis Inducer and a Multidrug Resistance Modulator in HL-60 Human Acute Myeloid Leukemia Cells" International Journal of Molecular Sciences 22, no. 19: 10597. https://doi.org/10.3390/ijms221910597